Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Phase II acromegaly study of ATL-1103 cleared to continue by DSMB

Nov. 28, 2013

Takeda Pharmaceutical divulges new MCH1 receptor antagonists for obesity

Nov. 27, 2013

Novel PKC-beta inhibitors synthesized at Sanofi

Nov. 26, 2013

GlaxoSmithKline patents new MCH1 receptor antagonists

Nov. 26, 2013

Canagliflozin approved in the E.U. for type 2 diabetes

Nov. 25, 2013

EMA's CHMP supports approval of Xigduo for type 2 diabetes

Nov. 25, 2013

Merck & Co. synthesizes new CETP inhibitors

Nov. 22, 2013

FDA committee recommends approval of Vimizim for mucopolysaccharidosis type IVA

Nov. 21, 2013

Novartis presents new DGAT1 inhibitors

Nov. 21, 2013

Clinical results for K-877, a novel PPAR-alpha receptor agonist, presented

Nov. 20, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...